Cargando…

Children with severe asthma can start allergen immunotherapy after controlling asthma with omalizumab: a case series from Poland

Detalles Bibliográficos
Autores principales:	Stelmach, Iwona, Majak, Paweł, Jerzyńska, Joanna, Bojo, Magdalena, Cichalewski, Łukasz, Smejda, Katarzyna
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Termedia Publishing House 2015
Materias:	Letter to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4548025/ https://www.ncbi.nlm.nih.gov/pubmed/26322106 http://dx.doi.org/10.5114/aoms.2015.48546

Ejemplares similares

Pediatric Asthma Caregiver’s Quality of Life Questionnaire is a useful tool for monitoring asthma in children
por: Stelmach, Iwona, et al.
Publicado: (2011)

Exhaled nitric oxide correlates with IL-2, MCP-1, PDGF-BB and TIMP-2 in exhaled breath condensate of children with refractory asthma
por: Brzozowska, Agnieszka, et al.
Publicado: (2015)

Omalizumab as a new therapeutic approach for children with severe asthma
por: Jerzyńska, Joanna, et al.
Publicado: (2014)

Associations between sensitization to perennial/seasonal allergens and childhood asthma
por: Kuzdak, M., et al.
Publicado: (2018)

Omalizumab in the prevention of anaphylaxis during immunotherapy: a case report
por: Stelmach, Iwona, et al.
Publicado: (2014)

Cytokine profiling in exhaled breath condensate after exercise challenge in asthmatic children with post-exercise symptoms
por: Majak, Paweł, et al.
Publicado: (2016)

Effectiveness of omalizumab in children and adolescents with uncontrolled allergic asthma: a case series from Poland
por: Sztafińska, Anna, et al.
Publicado: (2021)

Predictors of deterioration of lung function in Polish children with cystic fibrosis
por: Olszowiec-Chlebna, Małgorzata, et al.
Publicado: (2016)

Home Environment in Early-Life and Lifestyle Factors Associated with Asthma and Allergic Diseases among Inner-City Children from the REPRO_PL Birth Cohort
por: Kapszewicz, Katarzyna, et al.
Publicado: (2022)

Dog keeping at home before and during pregnancy decreased the risk of food allergy in 1-year-old children
por: Smejda, Katarzyna, et al.
Publicado: (2020)

Quality of life in asthmatic children and their caregivers after two-year treatment with omalizumab, a real-life study
por: Sztafińska, Anna, et al.
Publicado: (2017)

Allergic Rhinitis and House Dust Mite Sensitization Determine Persistence of Asthma in Children
por: Brzozowska, A., et al.
Publicado: (2022)

Effectiveness of the Polish program for the treatment of severe allergic asthma with omalizumab: a single-center experience
por: Kupryś-Lipińska, Izabela, et al.
Publicado: (2016)

Usefulness of sRtot and Rint in bronchodilator testing in the diagnosis of asthma in children
por: Bobrowska-Korzeniowska, Monika, et al.
Publicado: (2020)

Clinical and immunological effects of vitamin D supplementation during the pollen season in children with allergic rhinitis
por: Jerzyńska, Joanna, et al.
Publicado: (2016)

Food allergy is associated with recurrent respiratory tract infections during childhood
por: Woicka-Kolejwa, Katarzyna, et al.
Publicado: (2016)

Pretreatment by omalizumab allows allergen-specific immunotherapy in children and young adult with severe allergic asthma
por: Lambert, Nathalie, et al.
Publicado: (2015)

Allergen Immunotherapy in Asthma
por: Nakagome, Kazuyuki, et al.
Publicado: (2021)

Adolescent Athletes at Risk of Exercise-Induced Bronchoconstriction: A Result of Training or Pre-Existing Asthma?
por: Malewska-Kaczmarek, Kamila, et al.
Publicado: (2022)

Allergen-Specific Immunotherapy in Asthma
por: Jutel, Marek
Publicado: (2014)

Omalizumab in patients with severe uncontrolled asthma: well-defined eligibility criteria to promote asthma control
por: de Carvalho-Pinto, Regina Maria, et al.
Publicado: (2017)

270 Clinical Experience in Allergic Asthma Patients: Omalizumab with Immunotherapy
por: Yalcin, Arzu Didem, et al.
Publicado: (2012)

Omalizumab for Severe Asthma: Beyond Allergic Asthma
por: Loureiro, C. C., et al.
Publicado: (2018)

Allergen immunotherapy in asthma; what is new?
por: Passalacqua, Giovanni, et al.
Publicado: (2015)

Allergic asthma: An indication for allergen immunotherapy
por: Ankermann, Tobias, et al.
Publicado: (2023)

Severe asthma and the omalizumab option
por: Miller, Christopher WT, et al.
Publicado: (2008)

Omalizumab treatment in brittle asthma
por: Skiepko, Roman, et al.
Publicado: (2014)

4-month omalizumab efficacy outcomes for severe allergic asthma: the Dutch National Omalizumab in Asthma Registry
por: Snelder, S. M., et al.
Publicado: (2017)

Allergen-specific immunotherapy in pediatric allergic asthma
por: Yukselen, Ayfer
Publicado: (2016)

Omalizumab: Clinical Use for the Management of Asthma
por: Thomson, Neil C., et al.
Publicado: (2012)

Differential DNA methylation in allergen-specific immunotherapy of asthma
por: Wang, Chuang-Ming, et al.
Publicado: (2020)

Update on optimal use of omalizumab in management of asthma
por: Pelaia, Girolamo, et al.
Publicado: (2011)

279 Near-Fatal Asthma Treated with Omalizumab
por: Contreras Contreras, Elvia Angelica, et al.
Publicado: (2012)

A review of omalizumab for the management of severe asthma
por: Lin, Ching-Hsiung, et al.
Publicado: (2016)

Clinical and economic impact of a one-year treatment with omalizumab in patients with severe allergic asthma within a drug programme in Poland
por: Jahnz-Różyk, Karina, et al.
Publicado: (2018)

Allergen immunotherapy for allergic asthma: protocol for a systematic review
por: Dhami, Sangeeta, et al.
Publicado: (2016)

Personalized Medicine in Allergic Asthma: At the Crossroads of Allergen Immunotherapy and “Biologicals”
por: Fritzsching, Benedikt
Publicado: (2017)

Allergen Immunotherapy in Pediatric Asthma: A Pragmatic Point of View
por: Miraglia Del Giudice, Michele, et al.
Publicado: (2020)

Efficacy of Allergen Immunotherapy for Allergic Asthma in Real World Practice
por: Rhyou, Hyo-In, et al.
Publicado: (2019)

Omalizumab: the evidence for its place in the treatment of allergic asthma
por: McNicholl, Diarmuid M., et al.
Publicado: (2008)

Cannot write session to /tmp/vufind_sessions/sess_dostqv89p24f0hfufhhg5v3snk